Skip to main navigation Skip to search Skip to main content

Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)S111-S112
JournalMULTIPLE SCLEROSIS
Volume11
Publication statusPublished - 1 Jan 2005

Cite this